Presumptive false-positive amphetamine urine screen in a pregnant woman receiving α-methyldopa: A case report
Ömer Naim Sayer, Gamze Baytar, Hülya Kılıç, Koray Soytürk · 2026
Read Presumptive false-positive amphetamine urine screen in a pregnant woman receiving α-methyldopa: A case report by Ömer Naim Sayer, Gamze Baytar, Hülya Kılıç, Koray Soytürk (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13623244.txt.
Description
Ömer Naim Sayer and three co-authors report a pregnant woman whose urine drug screen falsely flagged amphetamine use in this 2026 case report. Quick immunoassay screens can cross-react with medicines, and reports in pregnancy are rare. The twenty-nine-year-old, at thirty-five weeks, was screened for a job medical.
She denied any drug use, and her exam and history were clean. Her regular medicines treated pregnancy hypertension, including alpha-methyldopa, whose breakdown product is known to interfere with some amphetamine assays. She had also taken an extra dose that morning. The authors present the case as most likely a false positive from the medicine. They warn that such results carry heavy consequences and deserve confirmatory testing.
Catalog record
| CREATOR | Ömer Naim Sayer, Gamze Baytar, Hülya Kılıç, Koray Soytürk |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 7 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |